| ID | Pathway map | Last update |
| 00010 | Glycolysis / Gluconeogenesis | 11-11-10 |
| 00020 | Citrate cycle (TCA cycle) | 11-6-30 |
| 00030 | Pentose phosphate pathway | 11-11-29 |
| 00040 | Pentose and glucuronate interconversions | 10-12-28 |
| 00051 | Fructose and mannose metabolism | 11-3-9 |
| 00052 | Galactose metabolism | 11-10-19 |
| 00053 | Ascorbate and aldarate metabolism | 10-12-28 |
| 00061 | Fatty acid biosynthesis | 11-5-28 |
| 00062 | Fatty acid elongation | 11-8-13 |
| 00071 | Fatty acid metabolism | 11-10-26 |
| 00072 | Synthesis and degradation of ketone bodies | 10-3-24 |
| 00073 | Cutin, suberine and wax biosynthesis | 11-8-25 |
| 00100 | Steroid biosynthesis | 11-12-7 |
| 00120 | Primary bile acid biosynthesis | 11-9-30 |
| 00121 | Secondary bile acid biosynthesis | 11-4-12 |
| 00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 11-11-22 |
| 00140 | Steroid hormone biosynthesis | 11-12-7 |
| 00190 | Oxidative phosphorylation | 11-10-19 |
| 00195 | Photosynthesis | 10-12-28 |
| 00196 | Photosynthesis - antenna proteins | 10-11-17 |
| 00230 | Purine metabolism | 11-10-15 |
| 00231 | Puromycin biosynthesis | 09-9-7 |
| 00232 | Caffeine metabolism | 11-9-16 |
| 00240 | Pyrimidine metabolism | 11-9-30 |
| 00250 | Alanine, aspartate and glutamate metabolism | 11-6-15 |
| 00253 | Tetracycline biosynthesis | 10-11-13 |
| 00260 | Glycine, serine and threonine metabolism | 11-2-3 |
| 00270 | Cysteine and methionine metabolism | 11-1-27 |
| 00280 | Valine, leucine and isoleucine degradation | 11-6-21 |
| 00281 | Geraniol degradation | 10-6-5 |
| 00290 | Valine, leucine and isoleucine biosynthesis | 11-7-29 |
| 00300 | Lysine biosynthesis | 11-12-7 |
| 00310 | Lysine degradation | 11-10-20 |
| 00311 | Penicillin and cephalosporin biosynthesis | 11-5-26 |
| 00312 | beta-Lactam resistance | 09-6-18 |
| 00330 | Arginine and proline metabolism | 11-12-7 |
| 00331 | Clavulanic acid biosynthesis | 09-9-24 |
| 00340 | Histidine metabolism | 11-8-23 |
| 00350 | Tyrosine metabolism | 11-12-1 |
| 00351 | DDT degradation | 10-12-27 |
| 00360 | Phenylalanine metabolism | 11-12-9 |
| 00361 | Chlorocyclohexane and chlorobenzene degradation | 11-6-25 |
| 00362 | Benzoate degradation | 11-6-21 |
| 00363 | Bisphenol degradation | 11-2-15 |
| 00364 | Fluorobenzoate degradation | 11-1-18 |
| 00380 | Tryptophan metabolism | 11-12-9 |
| 00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 11-11-18 |
| 00401 | Novobiocin biosynthesis | 11-11-15 |
| 00402 | Benzoxazinoid biosynthesis | 10-1-7 |
| 00410 | beta-Alanine metabolism | 11-8-23 |
| 00430 | Taurine and hypotaurine metabolism | 11-7-30 |
| 00440 | Phosphonate and phosphinate metabolism | 11-11-18 |
| 00450 | Selenocompound metabolism | 11-3-12 |
| 00460 | Cyanoamino acid metabolism | 11-6-22 |
| 00471 | D-Glutamine and D-glutamate metabolism | 11-3-15 |
| 00472 | D-Arginine and D-ornithine metabolism | 09-10-16 |
| 00473 | D-Alanine metabolism | 10-10-30 |
| 00480 | Glutathione metabolism | 11-8-23 |
| 00500 | Starch and sucrose metabolism | 10-12-27 |
| 00510 | N-Glycan biosynthesis | 11-9-7 |
| 00511 | Other glycan degradation | 11-2-3 |
| 00512 | Mucin type O-Glycan biosynthesis | 11-10-20 |
| 00513 | Various types of N-glycan biosynthesis | 11-9-7 |
| 00514 | Other types of O-glycan biosynthesis | 11-1-25 |
| 00520 | Amino sugar and nucleotide sugar metabolism | 11-11-18 |
| 00521 | Streptomycin biosynthesis | 10-12-27 |
| 00522 | Biosynthesis of 12-, 14- and 16-membered macrolides | 11-1-7 |
| 00523 | Polyketide sugar unit biosynthesis | 10-3-2 |
| 00524 | Butirosin and neomycin biosynthesis | 10-4-13 |
| 00531 | Glycosaminoglycan degradation | 11-9-3 |
| 00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate | 11-9-7 |
| 00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 10-5-19 |
| 00534 | Glycosaminoglycan biosynthesis - heparan sulfate | 10-3-9 |
| 00540 | Lipopolysaccharide biosynthesis | 11-11-26 |
| 00550 | Peptidoglycan biosynthesis | 11-11-18 |
| 00561 | Glycerolipid metabolism | 11-12-7 |
| 00562 | Inositol phosphate metabolism | 11-10-8 |
| 00563 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis | 10-11-9 |
| 00564 | Glycerophospholipid metabolism | 11-12-7 |
| 00565 | Ether lipid metabolism | 11-12-7 |
| 00590 | Arachidonic acid metabolism | 11-12-7 |
| 00591 | Linoleic acid metabolism | 11-12-3 |
| 00592 | alpha-Linolenic acid metabolism | 11-3-23 |
| 00600 | Sphingolipid metabolism | 11-12-7 |
| 00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 10-12-17 |
| 00603 | Glycosphingolipid biosynthesis - globo series | 09-9-3 |
| 00604 | Glycosphingolipid biosynthesis - ganglio series | 09-9-3 |
| 00620 | Pyruvate metabolism | 11-5-28 |
| 00621 | Dioxin degradation | 11-3-31 |
| 00622 | Xylene degradation | 10-12-2 |
| 00623 | Toluene degradation | 10-12-28 |
| 00624 | Polycyclic aromatic hydrocarbon degradation | 11-8-27 |
| 00625 | Chloroalkane and chloroalkene degradation | 11-1-18 |
| 00626 | Naphthalene degradation | 11-10-14 |
| 00627 | Aminobenzoate degradation | 11-6-21 |
| 00630 | Glyoxylate and dicarboxylate metabolism | 11-11-18 |
| 00633 | Nitrotoluene degradation | 10-12-2 |
| 00640 | Propanoate metabolism | 11-6-1 |
| 00642 | Ethylbenzene degradation | 11-9-17 |
| 00643 | Styrene degradation | 11-2-8 |
| 00650 | Butanoate metabolism | 11-6-21 |
| 00660 | C5-Branched dibasic acid metabolism | 10-3-2 |
| 00670 | One carbon pool by folate | 11-9-14 |
| 00680 | Methane metabolism | 11-12-10 |
| 00710 | Carbon fixation in photosynthetic organisms | 11-11-15 |
| 00720 | Carbon fixation pathways in prokaryotes | 11-10-18 |
| 00730 | Thiamine metabolism | 11-10-15 |
| 00740 | Riboflavin metabolism | 11-11-12 |
| 00750 | Vitamin B6 metabolism | 10-1-9 |
| 00760 | Nicotinate and nicotinamide metabolism | 11-7-23 |
| 00770 | Pantothenate and CoA biosynthesis | 11-4-13 |
| 00780 | Biotin metabolism | 11-2-3 |
| 00785 | Lipoic acid metabolism | 09-10-2 |
| 00790 | Folate biosynthesis | 11-7-1 |
| 00791 | Atrazine degradation | 11-2-22 |
| 00830 | Retinol metabolism | 11-12-13 |
| 00860 | Porphyrin and chlorophyll metabolism | 11-12-9 |
| 00900 | Terpenoid backbone biosynthesis | 11-5-12 |
| 00901 | Indole alkaloid biosynthesis | 09-10-10 |
| 00902 | Monoterpenoid biosynthesis | 11-10-12 |
| 00903 | Limonene and pinene degradation | 11-4-2 |
| 00904 | Diterpenoid biosynthesis | 10-9-8 |
| 00905 | Brassinosteroid biosynthesis | 11-11-16 |
| 00906 | Carotenoid biosynthesis | 11-10-1 |
| 00908 | Zeatin biosynthesis | 10-3-9 |
| 00909 | Sesquiterpenoid biosynthesis | 11-9-1 |
| 00910 | Nitrogen metabolism | 11-9-29 |
| 00920 | Sulfur metabolism | 11-8-20 |
| 00930 | Caprolactam degradation | 11-2-15 |
| 00940 | Phenylpropanoid biosynthesis | 11-12-9 |
| 00941 | Flavonoid biosynthesis | 11-9-9 |
| 00942 | Anthocyanin biosynthesis | 11-9-16 |
| 00943 | Isoflavonoid biosynthesis | 11-11-16 |
| 00944 | Flavone and flavonol biosynthesis | 11-10-22 |
| 00945 | Stilbenoid, diarylheptanoid and gingerol biosynthesis | 11-9-9 |
| 00950 | Isoquinoline alkaloid biosynthesis | 11-11-29 |
| 00960 | Tropane, piperidine and pyridine alkaloid biosynthesis | 11-12-16 |
| 00965 | Betalain biosynthesis | 09-9-3 |
| 00966 | Glucosinolate biosynthesis | 11-12-15 |
| 00970 | Aminoacyl-tRNA biosynthesis | 10-12-3 |
| 00980 | Metabolism of xenobiotics by cytochrome P450 | 11-12-3 |
| 00981 | Insect hormone biosynthesis | 11-5-12 |
| 00982 | Drug metabolism - cytochrome P450 | 10-12-28 |
| 00983 | Drug metabolism - other enzymes | 10-3-2 |
| 01010 | Overview of biosynthetic pathways | 09-7-29 |
| 01040 | Biosynthesis of unsaturated fatty acids | 10-12-28 |
| 01051 | Biosynthesis of ansamycins | 09-9-3 |
| 01052 | Type I polyketide structures | 11-2-24 |
| 01053 | Biosynthesis of siderophore group nonribosomal peptides | 11-12-2 |
| 01054 | Nonribosomal peptide structures | 11-2-24 |
| 01055 | Biosynthesis of vancomycin group antibiotics | 10-3-2 |
| 01056 | Biosynthesis of type II polyketide backbone | 11-3-12 |
| 01057 | Biosynthesis of type II polyketide products | 11-3-23 |
| 01058 | Acridone alkaloid biosynthesis | 11-10-7 |
| 01060 | Biosynthesis of plant secondary metabolites | 11-12-6 |
| 01061 | Biosynthesis of phenylpropanoids | 11-11-23 |
| 01062 | Biosynthesis of terpenoids and steroids | 11-12-13 |
| 01063 | Biosynthesis of alkaloids derived from shikimate pathway | 11-11-23 |
| 01064 | Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid | 11-11-23 |
| 01065 | Biosynthesis of alkaloids derived from histidine and purine | 11-11-23 |
| 01066 | Biosynthesis of alkaloids derived from terpenoid and polyketide | 11-11-23 |
| 01070 | Biosynthesis of plant hormones | 11-11-23 |
| 01100 | Metabolic pathways | 11-12-10 |
| 01110 | Biosynthesis of secondary metabolites | 11-12-10 |
| 01120 | Microbial metabolism in diverse environments | 11-12-10 |
| 02010 | ABC transporters | 11-12-7 |
| 02020 | Two-component system | 11-12-7 |
| 02030 | Bacterial chemotaxis | 10-7-8 |
| 02040 | Flagellar assembly | 11-12-7 |
| 02060 | Phosphotransferase system (PTS) | 10-3-3 |
| 03008 | Ribosome biogenesis in eukaryotes | 11-12-7 |
| 03010 | Ribosome | 11-12-7 |
| 03013 | RNA transport | 11-12-7 |
| 03015 | mRNA surveillance pathway | 11-12-7 |
| 03018 | RNA degradation | 11-12-7 |
| 03020 | RNA polymerase | 11-12-7 |
| 03022 | Basal transcription factors | 11-12-7 |
| 03030 | DNA replication | 11-12-7 |
| 03040 | Spliceosome | 11-12-7 |
| 03050 | Proteasome | 11-12-7 |
| 03060 | Protein export | 11-12-7 |
| 03070 | Bacterial secretion system | 11-12-7 |
| 03320 | PPAR signaling pathway | 11-12-7 |
| 03410 | Base excision repair | 11-12-7 |
| 03420 | Nucleotide excision repair | 11-12-7 |
| 03430 | Mismatch repair | 11-12-7 |
| 03440 | Homologous recombination | 11-12-7 |
| 03450 | Non-homologous end-joining | 11-8-2 |
| 03460 | Fanconi anemia pathway | 11-12-7 |
| 04010 | MAPK signaling pathway | 11-12-7 |
| 04011 | MAPK signaling pathway - yeast | 10-3-4 |
| 04012 | ErbB signaling pathway | 09-6-19 |
| 04013 | MAPK signaling pathway - fly | 09-7-1 |
| 04020 | Calcium signaling pathway | 11-12-7 |
| 04060 | Cytokine-cytokine receptor interaction | 11-12-7 |
| 04062 | Chemokine signaling pathway | 11-12-7 |
| 04070 | Phosphatidylinositol signaling system | 11-12-7 |
| 04075 | Plant hormone signal transduction | 11-2-15 |
| 04080 | Neuroactive ligand-receptor interaction | 11-12-7 |
| 04110 | Cell cycle | 10-9-6 |
| 04111 | Cell cycle - yeast | 10-4-14 |
| 04112 | Cell cycle - Caulobacter | 11-12-7 |
| 04113 | Meiosis - yeast | 10-4-14 |
| 04114 | Oocyte meiosis | 11-12-7 |
| 04115 | p53 signaling pathway | 10-9-6 |
| 04120 | Ubiquitin mediated proteolysis | 11-12-7 |
| 04122 | Sulfur relay system | 11-12-7 |
| 04130 | SNARE interactions in vesicular transport | 11-12-7 |
| 04140 | Regulation of autophagy | 10-9-6 |
| 04141 | Protein processing in endoplasmic reticulum | 11-12-7 |
| 04142 | Lysosome | 11-12-7 |
| 04144 | Endocytosis | 11-12-7 |
| 04145 | Phagosome | 11-12-7 |
| 04146 | Peroxisome | 11-12-7 |
| 04150 | mTOR signaling pathway | 11-12-7 |
| 04210 | Apoptosis | 11-12-7 |
| 04260 | Cardiac muscle contraction | 11-12-7 |
| 04270 | Vascular smooth muscle contraction | 10-9-6 |
| 04310 | Wnt signaling pathway | 11-12-7 |
| 04320 | Dorso-ventral axis formation | 10-3-2 |
| 04330 | Notch signaling pathway | 10-9-6 |
| 04340 | Hedgehog signaling pathway | 09-6-19 |
| 04350 | TGF-beta signaling pathway | 10-9-6 |
| 04360 | Axon guidance | 10-9-6 |
| 04370 | VEGF signaling pathway | 10-9-6 |
| 04380 | Osteoclast differentiation | 11-12-7 |
| 04510 | Focal adhesion | 11-12-7 |
| 04512 | ECM-receptor interaction | 11-12-7 |
| 04514 | Cell adhesion molecules (CAMs) | 11-1-13 |
| 04520 | Adherens junction | 11-12-7 |
| 04530 | Tight junction | 10-9-6 |
| 04540 | Gap junction | 11-12-7 |
| 04610 | Complement and coagulation cascades | 10-3-2 |
| 04612 | Antigen processing and presentation | 11-12-7 |
| 04614 | Renin-angiotensin system | 11-12-7 |
| 04620 | Toll-like receptor signaling pathway | 11-12-7 |
| 04621 | NOD-like receptor signaling pathway | 11-12-9 |
| 04622 | RIG-I-like receptor signaling pathway | 11-12-7 |
| 04623 | Cytosolic DNA-sensing pathway | 11-12-7 |
| 04626 | Plant-pathogen interaction | 11-12-7 |
| 04630 | Jak-STAT signaling pathway | 11-12-7 |
| 04640 | Hematopoietic cell lineage | 11-12-7 |
| 04650 | Natural killer cell mediated cytotoxicity | 11-12-7 |
| 04660 | T cell receptor signaling pathway | 11-12-7 |
| 04662 | B cell receptor signaling pathway | 11-12-7 |
| 04664 | Fc epsilon RI signaling pathway | 11-12-7 |
| 04666 | Fc gamma R-mediated phagocytosis | 11-12-7 |
| 04670 | Leukocyte transendothelial migration | 11-1-13 |
| 04672 | Intestinal immune network for IgA production | 11-12-7 |
| 04710 | Circadian rhythm - mammal | 11-12-7 |
| 04711 | Circadian rhythm - fly | 11-12-7 |
| 04712 | Circadian rhythm - plant | 09-6-19 |
| 04720 | Long-term potentiation | 11-12-7 |
| 04721 | Synaptic vesicle cycle | 11-12-7 |
| 04722 | Neurotrophin signaling pathway | 11-12-7 |
| 04724 | Glutamatergic synapse | 11-12-7 |
| 04725 | Cholinergic synapse | 11-12-7 |
| 04726 | Serotonergic synapse | 11-12-7 |
| 04727 | GABAergic synapse | 11-12-7 |
| 04728 | Dopaminergic synapse | 11-12-7 |
| 04730 | Long-term depression | 11-12-7 |
| 04740 | Olfactory transduction | 09-6-19 |
| 04742 | Taste transduction | 10-9-6 |
| 04744 | Phototransduction | 11-12-7 |
| 04745 | Phototransduction - fly | 11-12-7 |
| 04810 | Regulation of actin cytoskeleton | 11-12-7 |
| 04910 | Insulin signaling pathway | 11-12-7 |
| 04912 | GnRH signaling pathway | 11-12-7 |
| 04914 | Progesterone-mediated oocyte maturation | 11-12-7 |
| 04916 | Melanogenesis | 11-12-7 |
| 04920 | Adipocytokine signaling pathway | 11-12-7 |
| 04930 | Type II diabetes mellitus | 11-12-7 |
| 04940 | Type I diabetes mellitus | 11-12-7 |
| 04950 | Maturity onset diabetes of the young | 11-12-7 |
| 04960 | Aldosterone-regulated sodium reabsorption | 11-12-7 |
| 04961 | Endocrine and other factor-regulated calcium reabsorption | 11-12-7 |
| 04962 | Vasopressin-regulated water reabsorption | 11-12-7 |
| 04964 | Proximal tubule bicarbonate reclamation | 10-5-22 |
| 04966 | Collecting duct acid secretion | 10-5-22 |
| 04970 | Salivary secretion | 11-12-7 |
| 04971 | Gastric acid secretion | 11-12-7 |
| 04972 | Pancreatic secretion | 11-12-7 |
| 04973 | Carbohydrate digestion and absorption | 11-12-7 |
| 04974 | Protein digestion and absorption | 11-12-7 |
| 04975 | Fat digestion and absorption | 11-12-7 |
| 04976 | Bile secretion | 11-12-7 |
| 04977 | Vitamin digestion and absorption | 11-12-7 |
| 04978 | Mineral absorption | 11-12-7 |
| 05010 | Alzheimer's disease | 11-12-7 |
| 05012 | Parkinson's disease | 11-12-7 |
| 05014 | Amyotrophic lateral sclerosis (ALS) | 11-12-7 |
| 05016 | Huntington's disease | 11-12-7 |
| 05020 | Prion diseases | 11-12-7 |
| 05100 | Bacterial invasion of epithelial cells | 11-12-7 |
| 05110 | Vibrio cholerae infection | 11-12-7 |
| 05111 | Vibrio cholerae pathogenic cycle | 10-9-3 |
| 05120 | Epithelial cell signaling in Helicobacter pylori infection | 11-12-7 |
| 05130 | Pathogenic Escherichia coli infection | 11-12-7 |
| 05131 | Shigellosis | 11-12-7 |
| 05132 | Salmonella infection | 11-12-7 |
| 05133 | Pertussis | 11-12-7 |
| 05134 | Legionellosis | 11-12-7 |
| 05140 | Leishmaniasis | 11-12-7 |
| 05142 | Chagas disease (American trypanosomiasis) | 11-12-7 |
| 05143 | African trypanosomiasis | 11-12-7 |
| 05144 | Malaria | 11-12-7 |
| 05145 | Toxoplasmosis | 11-12-7 |
| 05146 | Amoebiasis | 11-12-7 |
| 05150 | Staphylococcus aureus infection | 11-12-7 |
| 05152 | Tuberculosis | 11-12-7 |
| 05160 | Hepatitis C | 11-12-7 |
| 05162 | Measles | 11-12-7 |
| 05164 | Influenza A | 11-12-7 |
| 05166 | HTLV-I infection | 11-12-7 |
| 05168 | Herpes simplex infection | 11-12-7 |
| 05200 | Pathways in cancer | 11-12-7 |
| 05202 | Transcriptional misregulation in cancers | 11-12-7 |
| 05210 | Colorectal cancer | 11-12-7 |
| 05211 | Renal cell carcinoma | 11-12-7 |
| 05212 | Pancreatic cancer | 11-12-7 |
| 05213 | Endometrial cancer | 10-9-6 |
| 05214 | Glioma | 11-12-7 |
| 05215 | Prostate cancer | 10-9-6 |
| 05216 | Thyroid cancer | 11-12-7 |
| 05217 | Basal cell carcinoma | 11-12-7 |
| 05218 | Melanoma | 11-12-7 |
| 05219 | Bladder cancer | 10-3-3 |
| 05220 | Chronic myeloid leukemia | 11-12-7 |
| 05221 | Acute myeloid leukemia | 11-12-7 |
| 05222 | Small cell lung cancer | 11-12-7 |
| 05223 | Non-small cell lung cancer | 11-12-7 |
| 05310 | Asthma | 11-12-7 |
| 05320 | Autoimmune thyroid disease | 11-12-7 |
| 05322 | Systemic lupus erythematosus | 11-12-7 |
| 05323 | Rheumatoid arthritis | 11-12-7 |
| 05330 | Allograft rejection | 11-12-7 |
| 05332 | Graft-versus-host disease | 11-12-7 |
| 05340 | Primary immunodeficiency | 11-12-7 |
| 05410 | Hypertrophic cardiomyopathy (HCM) | 11-12-7 |
| 05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 11-12-7 |
| 05414 | Dilated cardiomyopathy | 11-12-7 |
| 05416 | Viral myocarditis | 11-12-7 |
| 07011 | Penicillins | 10-12-28 |
| 07012 | Cephalosporins - parenteral agents | 10-12-28 |
| 07013 | Cephalosporins - oral agents | 10-3-3 |
| 07014 | Quinolones | 10-3-31 |
| 07015 | Local analgesics | 11-1-25 |
| 07016 | Sulfonamide derivatives - sulfa drugs | 10-3-3 |
| 07017 | Sulfonamide derivatives - diuretics | 11-5-29 |
| 07018 | Sulfonamide derivatives - hypoglycemic agents | 10-12-28 |
| 07019 | Tetracyclines | 10-8-20 |
| 07020 | Macrolides and ketolides | 10-12-28 |
| 07021 | Aminoglycosides | 10-3-3 |
| 07023 | Rifamycins | 10-12-28 |
| 07024 | Statins | 11-1-29 |
| 07025 | Quinolines | 10-4-10 |
| 07026 | Azoles | 10-4-10 |
| 07027 | Antidepressants | 11-1-26 |
| 07028 | Antipsychotics | 10-4-15 |
| 07029 | Phenothiazines | 11-1-25 |
| 07030 | Anxiolytics | 10-12-8 |
| 07031 | Butyrophenones | 11-1-26 |
| 07032 | Hypnotics | 11-3-31 |
| 07033 | Anticonvulsants | 10-12-28 |
| 07034 | Eicosanoids | 10-1-7 |
| 07035 | Prostaglandins | 10-12-28 |
| 07036 | Calcium channel blocking drugs | 11-3-3 |
| 07037 | Antiarrhythmic drugs | 11-5-14 |
| 07038 | Antacids | 11-5-27 |
| 07039 | Opioid analgesics | 10-4-27 |
| 07040 | Antineoplastics - alkylating agents | 11-11-23 |
| 07041 | Antineoplastics - antimetabolic agents | 10-3-31 |
| 07042 | Antineoplastics - agents from natural products | 09-12-10 |
| 07043 | Antineoplastics - hormones | 10-3-31 |
| 07044 | Antivirals | 10-8-7 |
| 07045 | Antineoplastics - protein kinases inhibitors | 11-3-31 |
| 07046 | Immunosuppressive agents | 10-12-28 |
| 07047 | Osteoporosis drugs | 10-3-3 |
| 07048 | Antimigraines | 10-8-13 |
| 07049 | Antithrombosis agents | 11-11-25 |
| 07110 | Benzoic acid family | 10-12-28 |
| 07111 | 2-Aminothiazole family | 10-12-28 |
| 07112 | 1,2-Diphenyl substitution family | 10-8-28 |
| 07113 | Furan family | 10-12-28 |
| 07114 | Naphthalene family | 10-9-2 |
| 07115 | Sulfonamide family | 10-8-31 |
| 07116 | Butyrophenone family | 11-1-29 |
| 07117 | Benzodiazepine family | 10-12-28 |
| 07211 | Serotonin receptor agonists/antagonists | 10-8-13 |
| 07212 | Histamine H1 receptor antagonists | 11-3-31 |
| 07213 | Dopamine receptor agonists/antagonists | 10-12-28 |
| 07214 | beta-Adrenergic receptor agonists/antagonists | 10-8-25 |
| 07215 | alpha-Adrenergic receptor agonists/antagonists | 10-5-15 |
| 07216 | Catecholamine transferase inhibitors | 10-12-28 |
| 07217 | Renin-angiotensin system inhibitors | 10-11-5 |
| 07218 | HIV protease inhibitors | 11-10-6 |
| 07219 | Cyclooxygenase inhibitors | 11-6-15 |
| 07220 | Cholinergic and anticholinergic drugs | 11-1-29 |
| 07221 | Nicotinic cholinergic receptor antagonists | 11-3-31 |
| 07222 | Peroxisome proliferator-activated receptor (PPAR) agonists | 10-12-28 |
| 07223 | Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists | 10-9-1 |
| 07224 | Opioid receptor agonists/antagonists | 11-4-1 |
| 07225 | Glucocorticoid and meneralocorticoid receptor agonists/antagonists | 10-7-23 |
| 07226 | Progesterone, androgen and estrogen receptor agonists/antagonists | 11-9-6 |
| 07227 | Histamine H2/H3 receptor agonists/antagonists | 10-8-26 |
| 07228 | Eicosanoid receptor agonists/antagonists | 10-9-29 |
| 07229 | Angiotensin receptor and endothelin receptor antagonists | 10-11-5 |
| 07230 | GABA-A receptor agonists/antagonists | 11-10-22 |
| 07231 | Sodium channel blocking drugs | 11-3-3 |
| 07232 | Potassium channel blocking and opening drugs | 11-6-14 |
| 07233 | Ion transporter inhibitors | 11-7-12 |
| 07234 | Neurotransmitter transporter inhibitors | 11-8-9 |
| 07235 | N-Metyl-D-aspartic acid receptor antagonists | 11-10-4 |